This indicates that glucagon secretion may be dysregulated in some PCOS patients, which could have the dual role of countering hypoglycemia while also contributing to hyperinsulinemia via the stimulatory effects of paracrine glucagon signaling on insulin secretion. The gene discussed is INS; the disease is polycystic ovary syndrome.